The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines

L CS Pinheiro, L M. Feitosa, M O. Gandi, F F. Silveira… - Molecules, 2019 - mdpi.com
Based on medicinal chemistry tools, new compounds for malaria treatment were designed.
The scaffolds of the drugs used to treat malaria, such as chloroquine, primaquine …

Evaluation of 7-arylaminopyrazolo [1, 5-a] pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors

LFSP Azeredo, JP Coutinho, VAP Jabor… - European Journal of …, 2017 - Elsevier
Malaria remains one of the most serious global infectious diseases. An important target for
antimalarial chemotherapy is the enzyme dihydroorotate dehydrogenase from Plasmodium …

[HTML][HTML] Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents

T Van de Walle, M Boone, J Van Puyvelde… - European Journal of …, 2020 - Elsevier
The parasitic disease malaria places almost half of the world's population at risk of infection
and is responsible for more than 400,000 deaths each year. The first-line treatment …

New Compounds Hybrids 1H‐1,2,3‐Triazole‐Quinoline Against Plasmodium falciparum

N Boechat, MLG Ferreira, LCS Pinheiro… - Chemical Biology & …, 2014 - Wiley Online Library
Malaria is one of the most prevalent parasitic diseases in the world. The global importance
of this disease, current vector control limitations, and the absence of an effective vaccine …

[HTML][HTML] New hybrid trifluoromethylquinolines as antiplasmodium agents

RMRJ da Silva, MO Gandi, JS Mendonça… - Bioorganic & Medicinal …, 2019 - Elsevier
Malaria remains a major public health problem worldwide, and it is responsible for high
rates of morbidity and mortality. Resistance to current antimalarial drugs has been identified …

Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: Further structure–activity relationships, in vivo studies, and preliminary toxicity profiling

S Gemma, C Camodeca… - Journal of medicinal …, 2012 - ACS Publications
Despite recent progress in the fight against malaria, the emergence and spread of drug-
resistant parasites remains a serious obstacle to the treatment of infections. We recently …

Novel amodiaquine congeners as potent antimalarial agents

M Casagrande, N Basilico, S Parapini, S Romeo… - Bioorganic & medicinal …, 2008 - Elsevier
To develop new classes of antimalarial agents, the possibility of replacing the phenolic ring
of amodiaquine, tebuquine, and isoquine with other aromatic nuclei was investigated. Within …

[HTML][HTML] Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity

ACC Aguiar, E Murce, WA Cortopassi… - International Journal for …, 2018 - Elsevier
In spite of recent efforts to eradicate malaria in the world, this parasitic disease is still
considered a major public health problem, with a total of 216 million cases of malaria and …

Chemotherapeutic agents against malaria: what next after chloroquine?

JN Domínguez - Current topics in medicinal chemistry, 2002 - europepmc.org
This is a general review of currently available antimalarial drugs, these compounds are
gathered according with its chemical structure and the biological targets. A great number of …

Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH …

FF Silveira, JO de Souza, LVB Hoelz… - European Journal of …, 2021 - Elsevier
In this work, we designed and synthesized 35 new triazolopyrimidine, pyrazolopyrimidine
and quinoline derivatives as P. falciparum inhibitors (3D7 strain). Thirty compounds …